Therapeutic Asset Ratings

3,186 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Allogeneic Cd123Car-Cd28-Cd3Zeta-Egfrt-Expressing T-Lymphocytes Adult Acute Lymphoblastic Leukemia	City of Hope Medical Center	P1	D (22)
Anti-B7-H3 Chimeric Antigen Receptor T-Cell /Tx103 Neoplasm	Tcelltech Inc.	P1	D (22)
Anti-Cll-1 Car Nk Cells Acute Myeloid Leukemia	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	P1	D (22)
Anti-Human Cd70 T-Cell Renal Cell Carcinoma	Hrain Biotechnology Co., Ltd.	P1	D (22)
Autologous Cd123Car-Cd28-Cd3Zeta-Egfrt-Expressing T Lymphocytes Acute Biphenotypic Leukemia	City of Hope Medical Center	P1	D (22)
Autologous Cd123Car-Cd28-Cd3Zeta-Egfrt-Expressing T Lymphocytes Adult Acute Lymphoblastic Leukemia	City of Hope Medical Center	P1	D (22)
Autologous Cd19Car-Cd28-Cd3Zeta-Egfrt-Expressing Tcm-Enriched T Cells Burkitt Lymphoma	City of Hope Medical Center	P1	D (22)
Autologous Cd19Car-Cd28-Cd3Zeta-Egfrt-Expressing Tn/Mem-Enriched T-Lymphocytes Burkitt Lymphoma	City of Hope Medical Center	P1	D (22)
b7-h3cart Neuroblastoma	Stanford University	P1	D (22)
b7-h3cart Osteosarcoma	Stanford University	P1	D (22)
b7-h3.cd28z.cart Neuroblastoma	Robbie Majzner	P1	D (22)
cd19-ucart Refractory Hematologic Cancer	iCell Gene Therapeutics	P1	D (22)
cd371-specific/ysnvz/i-18 car t cells Acute Myeloid Leukemia	Memorial Sloan Kettering Cancer Center	P1	D (22)
cd70-targeting car-t cells Renal Cell Carcinoma	Chongqing Precision Biotech Co., Ltd	P1	D (22)
Epcam Car-T Hepatocellular Carcinoma	Zhejiang University	P1	D (22)
Epcam Car-T Malignant Pancreatic Neoplasm	Zhejiang University	P1	D (22)
ic9-car.b7-h3 t cell therapy Refractory Malignant Neoplasm	UNC Lineberger Comprehensive Cancer Center	P1	D (22)
pd1-psma-cart cells Castration-Resistant Prostate Carcinoma	Zhejiang University	P1	D (22)
ucd7 cart Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P1	D (22)
Wu-Cart-007 Acute Myeloid Leukemia	Washington University School of Medicine	P1	D (22)
Anti-Cd19/Cd22 Car-T Cells Burkitt Lymphoma	First Affiliated Hospital Xi'an Jiaotong University	Early P1	D (22)
Anti-Psma Car-Nk Castration-Resistant Prostate Carcinoma	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	Early P1	D (22)
Autologous Car123 T Lymphocytes Myelodysplastic Syndrome	Institute of Hematology and Blood Transfusion, Czech Republic	Early P1	D (22)
b7h3 car-γδt cells Cancer	Peking University	Early P1	D (22)
Enhanced Autologous Psma-Car T Castration-Resistant Prostate Carcinoma	Shanghai Changzheng Hospital	Early P1	D (22)

Showing 2776 to 2800 of 3,186 assets

PreviousPage 112 of 128Next